11/29/24 17:00 | 11/27/24 | IDXX | Health | Diagn | In Vitro & In Vivo Diagnostic | Vandebroek Sophie V. | ME | D | | S | -145 | 420.44 | 0 | 0 | -28 | 1 | D | | | | | | | | | | | | | | |
9/9/24 16:18 | 9/6/24 | IDXX | BizSv | Paper | Manifold Business Forms | Szostak M Anne | ME | D | | S | -235 | 469.37 | 0 | -1 | -8 | 6 | I | | | | | | | | | | | | | | |
5/20/24 17:00 | 5/17/24 | IDXX | Health | Diagn | In Vitro & In Vivo Diagnostic | Claflin Bruce L. | ME | D | | S | -108 | 540.80 | 0 | 0 | -10 | 2 | D | | | | | | | | | | | | | | |
3/7/24 17:00 | 3/6/24 | IDXX | Health | Diagn | In Vitro & In Vivo Diagnostic | Polewaczyk James F | ME | O | EVP | S.d | -4,526 | 558.44 | 0 | -8 | -43 | 11 | D | | | | | | | | | | | | | | |
3/7/24 17:00 | 3/5/24 | IDXX | Health | Diagn | In Vitro & In Vivo Diagnostic | Vandebroek Sophie V. | ME | D | | S.d | -790 | 562.98 | 0 | -1 | -13 | 9 | D | | | | | | | | | | | | | | |
2/9/24 17:03 | 2/8/24 | IDXX | Health | Diagn | In Vitro & In Vivo Diagnostic | Fennell George | ME | O | SVP,Chie | S.d | -4,705 | 573.87 | 0 | -8 | -55 | 7 | D | | | | | | | | | | | | | | |
2/9/24 17:01 | 2/7/24 | IDXX | Health | Diagn | In Vitro & In Vivo Diagnostic | McKeon Brian P | ME | O | EVP,CFO, | S.d | -13,296 | 570.01 | 0 | -23 | -33 | 48 | D | | | | | | | | | | | | | | |
2/9/24 17:00 | 2/7/24 | IDXX | Health | Diagn | In Vitro & In Vivo Diagnostic | Mazelsky Jonathan Jay | ME | DO | P,CEO | S.d | -6,871 | 572.61 | 0 | -12 | -13 | 79 | D | | | | | | | | | | | | | | |
12/8/23 17:00 | 12/7/23 | IDXX | Health | Diagn | In Vitro & In Vivo Diagnostic | Polewaczyk James F | ME | O | EVP | S.d | -6,072 | 521.79 | 0 | -12 | -54 | 10 | D | | | | | | | | | | | | | | |
12/6/23 17:01 | 12/4/23 | IDXX | Health | Diagn | In Vitro & In Vivo Diagnostic | Mazelsky Jonathan Jay | ME | DO | P,CEO | S.d | -3,657 | 513.05 | 0 | -7 | -8 | 79 | D | | | | | | | | | | | | | | |
9/5/23 17:01 | 8/31/23 | IDXX | Health | Diagn | In Vitro & In Vivo Diagnostic | Mazelsky Jonathan Jay | ME | DO | P,CEO | S.d | -6,873 | 512.01 | 0 | -13 | -16 | 73 | D | | | | | | | | | | | | | | |
8/31/23 17:17 | 8/29/23 | IDXX | Health | Diagn | In Vitro & In Vivo Diagnostic | Polewaczyk James F | ME | O | EVP | S.d | -11,696 | 510.56 | 0 | -23 | -70 | 10 | D | | | | | | | | | | | | | | |
8/17/23 19:37 | 8/15/23 | IDXX | Health | Diagn | In Vitro & In Vivo Diagnostic | Ayers Jonathan W | ME | D | | S | 0 | 0.00 | 0 | 0 | 0 | 596 | D | | | | | | | | | | | | | | |
8/7/23 17:04 | 8/3/23 | IDXX | Health | Diagn | In Vitro & In Vivo Diagnostic | Lane Michael | ME | O | EVP | S.d | -8,174 | 510.00 | 0 | -16 | -78 | 5 | D | | | | | | | | | | | | | | |
5/22/23 17:00 | 5/18/23 | IDXX | Health | Diagn | In Vitro & In Vivo Diagnostic | Ayers Jonathan W | ME | D | | S.dm | -9,806 | 490.29 | 0 | -20 | -3 | 597 | D | | | | | | | | | | | | | | |
5/8/23 17:03 | 5/5/23 | IDXX | BizSv | Paper | Manifold Business Forms | Szostak M Anne | ME | D | | S | -950 | 474.90 | 0 | -2 | -25 | 6 | I | | | | | | | | | | | | | | |
5/8/23 17:01 | 5/5/23 | IDXX | Health | Diagn | In Vitro & In Vivo Diagnostic | Lane Michael | ME | O | EVP | S | -484 | 484.00 | 0 | -1 | -18 | 5 | D | | | | | | | | | | | | | | |
5/5/23 18:01 | 5/4/23 | IDXX | Health | Diagn | In Vitro & In Vivo Diagnostic | Vandebroek Sophie V. | ME | D | | S.d | -1,026 | 469.02 | 0 | -2 | -19 | 9 | M | | | | | | | | | | | | | | |
2/17/23 17:06 | 2/16/23 | IDXX | Health | Diagn | In Vitro & In Vivo Diagnostic | Junius Daniel M | ME | D | | S.d | -1,119 | 511.68 | 0 | -2 | -42 | 3 | D | | | | | | | | | | | | | | |
2/17/23 17:04 | 2/15/23 | IDXX | Health | Diagn | In Vitro & In Vivo Diagnostic | Turner Kathy V | ME | O | SVP | S.dm | -515 | 510.09 | 0 | -1 | -12 | 7 | D | | | | | | | | | | | | | | |
2/16/23 18:56 | 2/14/23 | IDXX | Health | Diagn | In Vitro & In Vivo Diagnostic | Turner Kathy V | ME | O | SVP | S.d | -1,009 | 504.59 | 0 | -2 | -21 | 7 | D | | | | | | | | | | | | | | |
2/13/23 17:01 | 2/9/23 | IDXX | Health | Diagn | In Vitro & In Vivo Diagnostic | Turner Kathy V | ME | O | SVP | S.d | -505 | 505.04 | 0 | -1 | -12 | 7 | D | | | | | | | | | | | | | | |
12/7/22 16:30 | 12/5/22 | IDXX | Health | Diagn | In Vitro & In Vivo Diagnostic | Junius Daniel M | ME | D | | S.d | -1,294 | 424.91 | 0 | -3 | -51 | 3 | D | | | | | | | | | | | | | | |
12/6/22 17:01 | 12/2/22 | IDXX | BizSv | Paper | Manifold Business Forms | Szostak M Anne | ME | D | | S.d | -317 | 428.55 | 0 | -1 | -8 | 9 | D | | | | | | | | | | | | | | |
12/5/22 17:00 | 12/1/22 | IDXX | Health | Diagn | In Vitro & In Vivo Diagnostic | Turner Kathy V | ME | O | SVP | S.d | -1,308 | 436.00 | 0 | -3 | -30 | 7 | D | | | | | | | | | | | | | | |
11/16/22 17:00 | 11/14/22 | IDXX | Health | Diagn | In Vitro & In Vivo Diagnostic | Mazelsky Jonathan Jay | ME | DO | P,CEO | S.d | -4,562 | 434.47 | 0 | -11 | -13 | 71 | D | | | | | | | | | | | | | | |
11/14/22 17:00 | 11/10/22 | IDXX | Health | Diagn | In Vitro & In Vivo Diagnostic | Turner Kathy V | ME | O | SVP | S.dm | -5,921 | 426.71 | 0 | -14 | -66 | 7 | D | | | | | | | | | | | | | | |
11/9/22 17:00 | 11/7/22 | IDXX | Health | Diagn | In Vitro & In Vivo Diagnostic | Mazelsky Jonathan Jay | ME | DO | P,CEO | S.d | -5,060 | 382.49 | 0 | -13 | -18 | 62 | D | | | | | | | | | | | | | | |